Inovio Pharmaceuticals
INO
#8897
Rank
A$0.21 B
Marketcap
A$3.12
Share price
2.48%
Change (1 day)
-50.00%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.11 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's total liabilities are A$0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Inovio Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$71.85 M-8.67%
2023-12-31A$78.67 M-57.57%
2022-12-31A$0.18 B39.62%
2021-12-31A$0.13 B29.86%
2020-12-31A$0.10 B-48.32%
2019-12-31A$0.19 B216.25%
2018-12-31A$62.57 M9.16%
2017-12-31A$57.32 M-17.9%
2016-12-31A$69.82 M34.18%
2015-12-31A$52.03 M110.33%
2014-12-31A$24.74 M-37.63%
2013-12-31A$39.66 M300.96%
2012-12-31A$9.89 M-23.41%
2011-12-31A$12.91 M46.34%
2010-12-31A$8.82 M-59.22%
2009-12-31A$21.64 M-23.19%
2008-12-31A$28.17 M181.87%
2007-12-31A$9.99 M-36.69%
2006-12-31A$15.79 M109.76%
2005-12-31A$7.52 M7.84%
2004-12-31A$6.98 M339.22%
2003-12-31A$1.58 M-47.14%
2002-12-31A$3 M-8.16%
2001-12-31A$3.27 M
2001-03-31A$3.3 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
A$174.08 B 149,869.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$170.93 B 147,151.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$1.29 B 1,016.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$94.14 B 81,005.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$116.88 B 100,591.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$92.26 B 79,381.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
A$55.81 B 47,986.00%๐Ÿ‡บ๐Ÿ‡ธ USA